News and blog posts

16

Jan 2020

New material codes for implantable non-rechargeable neurostimulator, electrodes, and extensions for stimulation of the dorsal root nodes were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in December 2019. Read more

15

Jan 2020

Dutch Healthcare Authority (NZa) has released key features of the DRG package for 2021, including complex chronic lung failure, stem cell transplant care, indexation of DRG tariffs, and position about reimbursment of MammaPrint test. Read more

14

Jan 2020

In December 2019, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance (for balloon dilation for chronic eustachian tube dysfunction), one new medical technologies guidance (for gammaCore for cluster headache), and five new MedTech innovation briefings (for Optowire for measuring fractional flow reserve, eXroid for internal hemorrhoids, and others). Read more

13

Jan 2020

In mid-December 2019, the Swiss Federal Department for Home Affairs (FDHA) has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of leukemia and lymphoma will be reimbursed by compulsory health care insurance. Read more

11

Jan 2020

On the week of 6th of January, MTRC published several posts related to the process of DRG change in England, list of technologies with different levels of added value (ASA) in France, countries offering access to hospital procedure volume information, improvements with glaucoma minimally invasive surgery reimbursement in England, the role of DRG in Scandinavia, and list of countries actively using DRG system for case-by-case reimbursement. Follow us on Instagram on mtrc.market.access Read more

07

Jan 2020

In mid-November 2019, the report of the project OTCA20, titled “Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)” was published on the website of the European Network for HTA (EUnetHTA). Read more

06

Jan 2020

At the start of the organized program for the early detection of cervical cancer on January 1, 2020, several new services will be added to the EBM (Einheitlicher Bewertungsmaβstab, German Uniform Evaluation Standard). Read more

03

Jan 2020

In early November 2019, the report of the project OTCA18, titled “Regional hyperthermia for high-risk soft tissue sarcoma treatment” was published on the website of the European Network for HTA (EUnetHTA). Read more

30

Dec 2019

On November 7, 2019, the Nomenclature was updated. The update brought changes in chapter V of Nomenclature, regarding the creation of new codes and modification of existing codes. Read more

27

Dec 2019

On the 20th of November, the Danish Health Authority (Sundhedsstyrelsen) has published a national clinical guideline for the oxygen therapy of acutely ill adult patients. Read more

26

Dec 2019

We will share selective news, opinions, commentary, and analysis on the topic of European market access for medical technologies on Instagram. We are planning to develop specific content for Instagram, not fully matching the content of our websites. You can find our account at mtrc.market.access Read more

26

Dec 2019

In late November 2019, the network of European HTA agencies, EUnetHTA, announced the final plan of the project OTCA23 “Biodegradable rectum spacers to reduce toxicity for prostate cancer.” Read more